The Role of Prophylactic Central Compartment Neck Dissection in the Management of 2 to 4 Cm Papillary Thyroid Carcinoma
Launched by LEONARDO ROSSI · Mar 20, 2025
Trial Information
Current as of April 22, 2025
Not yet recruiting
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. PTC documented by fine needle aspiration cytology (FNAC) (TIR 4 or TIR 5 according to the Italian consensus for the classification and reporting of thyroid cytology \[15\]);
- • 2. no pre-operative evidence of lymph node metastases (cN0) at palpation and neck ultrasound (US);
- • 3. no clinical evidence of distant metastasis at diagnosis;
- • 4. age ≥ 18 years.
- Exclusion Criteria:
- • 1. histotypes other than PTC;
- • 2. evidence of lymph node metastases during surgery even if not previously diagnosed;
- • 3. presence of distant metastasis.
About Leonardo Rossi
Leonardo Rossi is a dedicated clinical trial sponsor committed to advancing medical research and improving patient outcomes through innovative therapeutic solutions. With a focus on rigorous scientific methodology and ethical standards, Mr. Rossi oversees clinical studies that span various therapeutic areas, ensuring robust data collection and analysis. His extensive experience in clinical operations and strategic planning enables the successful execution of trials, fostering collaboration with healthcare professionals and regulatory bodies. Through a patient-centered approach, Leonardo Rossi aims to contribute significantly to the development of safe and effective treatments that address unmet medical needs.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported